Literature DB >> 35064266

Neurobiology of Psychosis and Schizophrenia 2021: Nottingham Meeting.

Musa Basseer Sami1,2, Peter Liddle1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35064266      PMCID： PMC8886577          DOI： 10.1093/schbul/sbab152

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  22 in total

1.  Effects of social isolation rearing on the limbic brain: a combined behavioral and magnetic resonance imaging volumetry study in rats.

Authors:  M I Schubert; M V Porkess; N Dashdorj; K C F Fone; D P Auer
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

2.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.

Authors:  Sang-Young Kim; Bruce M Cohen; Xi Chen; Scott E Lukas; Ann K Shinn; A Cagri Yuksel; Tao Li; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2016-09-24       Impact factor: 9.306

3.  In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.

Authors:  Antonio Napolitano; Khalid Shah; Mirjam I Schubert; Veronica Porkess; Kevin C F Fone; Dorothee P Auer
Journal:  Schizophr Bull       Date:  2013-05-13       Impact factor: 9.306

4.  In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.

Authors:  Fei Du; Alissa J Cooper; Thida Thida; Selma Sehovic; Scott E Lukas; Bruce M Cohen; Xiaoliang Zhang; Dost Ongür
Journal:  JAMA Psychiatry       Date:  2014-01       Impact factor: 21.596

5.  The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats.

Authors:  Allison L McIntosh; Theresa M Ballard; Lucinda J Steward; Paula M Moran; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2013-02-09       Impact factor: 4.530

6.  Bioenergetics and abnormal functional connectivity in psychotic disorders.

Authors:  Xiaopeng Song; Xi Chen; Cagri Yuksel; Junliang Yuan; Diego A Pizzagalli; Brent Forester; Dost Öngür; Fei Du
Journal:  Mol Psychiatry       Date:  2021-01-04       Impact factor: 13.437

7.  5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.

Authors:  Julie Meffre; Séverine Chaumont-Dubel; Clotilde Mannoury la Cour; Florence Loiseau; David J G Watson; Anne Dekeyne; Martial Séveno; Jean-Michel Rivet; Florence Gaven; Paul Déléris; Denis Hervé; Kevin C F Fone; Joël Bockaert; Mark J Millan; Philippe Marin
Journal:  EMBO Mol Med       Date:  2012-10       Impact factor: 12.137

8.  The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis.

Authors:  James G Scott; David Gillis; Alex E Ryan; Hethal Hargovan; Nagaraj Gundarpi; Gemma McKeon; Sean Hatherill; Martin P Newman; Peter Parry; Kerri Prain; Sue Patterson; Richard C W Wong; Robert J Wilson; Stefan Blum
Journal:  BJPsych Open       Date:  2018-03-16

Review 9.  The Core Deficit of Classical Schizophrenia: Implications for Predicting the Functional Outcome of Psychotic Illness and Developing Effective Treatments.

Authors:  Peter F Liddle
Journal:  Can J Psychiatry       Date:  2019-08-21       Impact factor: 4.356

10.  Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients.

Authors:  Nian Liu; Yuan Xiao; Wenjing Zhang; Biqiu Tang; Jiaxin Zeng; Na Hu; Shah Chandan; Qiyong Gong; Su Lui
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.